News

BMY depends on Reblozyl, Opdualag and Breyanzi to offset revenue hits from generics and Medicare Part D impacts.
Supreme Court widens court options for vaping companies pushing back against FDA rules by: LINDSAY WHITEHURST, Associated Press Posted: Jun 20, 2025 / 01:53 PM CDT Updated: Jun 20, 2025 / 02:16 PM CDT ...
Supreme Court widens court options for vaping companies pushing back against FDA rules by: LINDSAY WHITEHURST, Associated Press Posted: Jun 20, 2025 / 01:53 PM CDT Updated: Jun 20, 2025 / 01:57 PM CDT ...
In today’s issue: Supreme Court rules against FDA, EPA Trump calls for review of 2020 election Senate parliamentarian eyes ‘big, beautiful’ bill ChatGPT’s impact on critical thinking ...
The conservative 5th U.S. Circuit Court of Appeals allowed the lawsuit to go forward, finding that anyone whose business is hurt by the FDA decision can sue.
Supreme court widens court options for vaping companies pushing back against FDA rules By LINDSAY WHITEHURST The Associated Press,Updated June 20, 2025, 2:39 p.m.
Currently, the FDA has a deadline of 10 months after a company files a drug application to make an approval decision. That review period is shortened to six months if a company has been granted a ...
FDA Approves Yeztugo as First Twice-Yearly Injectable HIV Prevention Option in the U.S. Clinical Trials Show Near-Perfect Efficacy With 99.9% of Pa ...
The Food and Drug Administration (FDA) has approved Harliku ™ (nitisinone) for the reduction of urine homogentisic acid (HGA) in adult patients with alkaptonuria. Alkaptonuria (AKU) is a rare ...
The U.S. Food and Drug Administration (FDA) on June 18 approved a newly developed HIV/AIDS prevention drug that only needs to be taken by injection once every six months. The new drug, lenacapavir ...
FDA approves new twice-yearly HIV prevention shot. Here's how it works By Daniel Miller Published June 19, 2025 7:56am PDT Health ...
FDA approves new twice-yearly HIV prevention shot. Here's how it works By Daniel Miller Published June 19, 2025 9:56am CDT Health ...